US Patent Litigations are now available. Check here

Explore patent oppositions filed by The Medicines against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jun 12, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP1857547Further Novel Forms Of Interfering Rna MoleculesATUGENOct 16, 2018
EP2258847Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICSDec 14, 2017

Explore The Medicines's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3529360Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction5